ArticleJournal of thoracic disease2026
IL-15/NKG2D signaling-mediated activation of CD8
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sepsis is a systemic inflammatory response syndrome (SIRS) caused by infection, accompanied by immune dysregulation, leading to a high mortality rate. Memory CD8 Methods: A mouse sepsis model was set up using cecum ligation and puncture (CLP), and the progression of sepsis was observed through IL-15 intervention. Serum inflammatory factors and organ damage markers [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), blood urea nitrogen (BUN), creatinine (CREA)] were detected by ELISA and biochemical analysis. HE staining was employed to assess pathological alterations in the spleen and multiple organ tissues. Immunohistochemical analysis was performed to detect CD8 expression in the liver, lung, kidney, and spleen. Flow cytometry was used to analyze the expression of NKG2D, initiation markers (CD38/HLA-DR), and effector molecules [Granzyme B, interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α)] in splenic CD44 Results: Exogenous IL-15 significantly aggravated multi-organ damage (elevated AST, ALT, LDH, BUN, and CREA) and systemic inflammatory response in septic mice. Histopathological examination revealed splenic lymphocyte necrosis and worsening liver and kidney damage. Exogenous administration of IL-15 significantly enhances the recruitment and infiltration of CD8 Conclusions: IL-15 activates a TCR-independent bypass activation pathway by inducing NKG2D expression on memory CD8
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.